Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Feras Almarshad
Caplacizumab: First FDA-approved Therapy in 2019 for the Treatment of Adult Patients With Acquired Thrombotic Thrombocytopenic Purpura
NeuroPharmac Journal
Autism Spectrum Disorder: Medications Overview
NeuroPharmac Journal
Related publications
Acquired Thrombotic Thrombocytopenic Purpura
Additional Autoimmune Disorders in Patients With Acquired Autoimmune Thrombotic Thrombocytopenic Purpura
American Journal of Hematology
Hematology
Blue Nose Syndrome in Acquired Thrombotic Thrombocytopenic Purpura
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Thrombotic Thrombocytopenic Purpura
American Journal of Medicine
Medicine
Thrombotic Thrombocytopenic Purpura
Laboratory Medicine
Biochemistry
Clinical Biochemistry
Modifying ADAMTS13 to Modulate Binding of Pathogenic Autoantibodies of Patients With Acquired Thrombotic Thrombocytopenic Purpura
Haematologica
Hematology
Long-Term Neuropsychological Sequelae, Emotional Wellbeing and Quality of Life in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Haematologica
Hematology
Thrombotic Thrombocytopenic Purpura Associated With Pneumococcal Sepsis
Canadian Journal of Infectious Diseases
Bolus Methylprednisolone Therapy in Adult Idiopathic Thrombocytopenic Purpura.
Japanese Journal of Medicine
